International Journal of Head and Neck Surgery

Register      Login

VOLUME 12 , ISSUE 1 ( January-March, 2021 ) > List of Articles

Otology Research Article

Sustained Release of Antimicrobials in the Middle Ear Using a Biodegradable Support: Ototoxicity Studies

Marcos V Goycoolea, David D Muchow

Citation Information : Goycoolea MV, Muchow DD. Sustained Release of Antimicrobials in the Middle Ear Using a Biodegradable Support: Ototoxicity Studies. Int J Head Neck Surg 2021; 12 (1):19-21.

DOI: 10.5005/jp-journals-10001-1409

License: CC BY-NC 4.0

Published Online: 31-03-2021

Copyright Statement:  Copyright © 2021; The Author(s).


Abstract

Introduction: This study was one more step of a systematic approach for the development of a poly-L-lactic biodegradable support matrix incorporating a therapeutically releasable amount of ampicillin. In vitro studies (3 months) documented the sustained release of therapeutic levels of antimicrobial.1 In vivo efficacy was demonstrated in otitis media-induced chinchillas (S. pneumoniae) and cats (Eustachian tube obstruction).2 Histopathological studies in cats documented a lack of inflammatory reaction from the device itself, and its capacity of being biodegradable.2 Aims and objectives: This step evaluates potential hair damage to this device. Materials and methods: Morphometry of the organ of Corti (hair cell count) was done in 14 chinchillas exposed to these devices for 3 weeks (7 with and 7 without ampicillin). Results: There were no qualitative changes in the stereocilia nor in the cell bodies of hair cells. The morphology of hair cells in the control sides and the sides with the experimental devices is the same. Conclusion: Poly-L-lactic acid biodegradable support matrix incorporating a therapeutically releasable amount of ampicillin does not cause hair cell morphological damage when inserted in the middle ear of chinchillas.


HTML PDF Share
  1. In search of missing links in otology. part II: development of an implantable middle ear drug delivery system; initial studies of sustained ampicillin release for the treatment of otitis media. Laryngoscope 1991;101(7):727–732. DOI: 10.1288/00005537-199107000-00006.
  2. Extended middle ear drug delivery. A new concept, a new device. Acta Otolaryngol (Stockh) 1992;Suppl. 493:119–126.
  3. Morphometry of the chinchilla organ of Corti and stria vascularis. J Histochem Cytochem 1979;27(11):1539–1542. DOI: 10.1177/27.11.512345.
  4. Irreversible inner ear damage from rock music. Trans Am Acad Ophtalmol Otolaryngol 1976;82:50–59.
  5. Otitis media; 16 years of pathogenesis approach. Otolarung Clin North Amer 1991;24(4):967–980. DOI: 10.1016/S0030-6665(20)31103-8.
  6. Degradable implant materials; a review of synthetic absorbable polymers and their applications. Clin Mater 1986;1(4):233–257. DOI: 10.1016/S0267-6605(86)80015-4.
  7. Polylactic acid for surgical implants. Arch Surg 1966;93(5):839–843. DOI: 10.1001/archsurg.1966.01330050143023.
  8. Poly (lactic acid)/poly (lactic-co-glycolic acid)- based microparticles: an overview. J Pharmaceut Investigat 2019;49(4):337–346. DOI: 10.1007/s40005-019-00453-z.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.